Inclisiran (Leqvio®) orders for NHS prescriptions – check your invoices
Community pharmacies are reminded that Inclisiran (Leqvio®) 284mg/1.5ml solution for injection pre-filled syringe is available to order from the nominated wholesaler AAH UK at a nominal charge of £45 per pack for supply against NHS prescriptions, as agreed within the commercial agreement between Novartis Pharmaceuticals UK Ltd and NHS England. A summary of the current NHS funding and supply arrangements for Inclisiran (Leqvio®) can be found here.
For NHS orders of Inclisiran (Leqvio®), the nominal price should be reflected in your wholesaler invoice and pharmacies should not expect to incur any additional charges or fees from AAH UK. However, Community Pharmacy England has received a few reports of some pharmacies being incorrectly charged the full NHS list price of £1987.36 per pack instead of the nominal price of £45. Pharmacy teams are advised to check their wholesaler invoices to ensure they have been charged the correct price by AAH UK for Inclisiran (Leqvio®).
Pharmacies that have been charged incorrectly for NHS orders of Inclisiran (Leqvio®) can request a repayment of any additional costs. In this first instance, pharmacies are advised to contact AAH UK directly. If the issue remains unresolved, the query can be escalated to Novartis Pharmaceuticals UK directly on 08457 419 442 or via e-mail commercial.team@novartis.com. To support investigation of any pricing issues, pharmacies should submit copies of invoices to AAH UK and Novartis Pharmaceuticals UK. Should no resolution be identified by the suppliers within 5 working days of receipt, then contractors should escalate to Community Pharmacy England.
Please note for dispensing against private prescriptions, stock must be obtained directly from Novartis Pharmaceuticals UK Ltd by contacting Novartis Customer Care on 08457 419 442 or via e-mail commercial.team@novartis.com. This will be charged at the current full NHS list price of £1987.36 per pack.
Background to the inclusion of Inclisiran (Leqvio®) in Part VIIIC of the Drug Tariff
Inclisiran (Leqvio®) is listed in Part VIIIC of the Drug Tariff.
Products listed in Part VIIIC are available at nominal prices because of commercial deals in place between the manufacturer or supplier and NHS England which allows manufacturers to supply a drug to the NHS at a reduced cost compared to its published NHS list prices as authored in the NHS Dictionary of Medicines and Devices (dm+d).
Part VIIIC also includes products which the Secretary of State has centrally secured and has made arrangements for the product to be supplied to pharmacies, whether directly or via an intermediary, at no cost to the pharmacy for example, COVID-19 antiviral treatments.
Further information on Part VIIIC can be found here.
For any queries regarding the supply and reimbursement of Inclisiran (Leqvio®), please contact our Dispensing and Supply Team by emailing ds.team@cpe.org.uk.